Abstract: An abradable coating for a turbomachine part, includes a matrix made of a first metal material and particles made of a second metal material that are dispersed in the matrix, the first metal material having a melting temperature greater than 900° C., the second metal material having a melting temperature at least 50° C. lower than the melting temperature of the first metal material.

Abstract: The present disclosure relates to a method for treating an electromembrane process aqueous composition comprising sodium and/or potassium sulfate, said process comprising removing water from said electromembrane process aqueous composition under conditions suitable for substantially selectively precipitating sodium and/or potassium sulfate monohydrate.

Abstract: Systems and methods for optimizing asset maintenance protocols by predicting vegetation-driven outages are disclosed. An example method includes determining, by one or more processors, a failure probability for each asset in a set of assets within a designated area. The example method further includes defining, by the one or more processors, an asset risk for each asset in the set of assets based on the failure probability, and clustering, by the one or more processors, vegetation within the designated area to determine a predicted vegetation-driven outage. The example method further includes optimizing, by the one or more processors, a set of asset maintenance protocols corresponding to the set of assets based on the asset risk and the predicted vegetation-driven outage.

Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.

Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.

Abstract: A textile jet subassembly includes a textile jet or jet nozzle mounted on a base support. An upper impact plate and a lower insert plate form the yarn channel passing through the jet or jet nozzle. A jet interface and a threading slot communicate with the yarn channel and the sidewalls above and below the threading slot are coplanar to form a smooth surface. Multiple alignment or registration recesses and cooperating pin fasteners are spaced from the yarn channel on the same side of the yarn channel to properly align the side walls above and below the threading slot.

Abstract: A pump device (1) for administering a medical fluid to a patient comprises a holding device (10) for receiving a syringe barrel (20) of a syringe (2), the holding device (10) comprising a stationary section (101) and a holding member (11) movable with respect to the stationary section (101) between an opened position and a closed position, wherein the holding member (11) is configured to secure, in the closed position, the syringe barrel (20) of a syringe (2) received on the holding device (10) with respect to the stationary section (101). A shaft (130) is coupled to the holding member (11), the shaft (130) being constituted to rotate during a movement of the holding member (11).

Abstract: The present disclosure provides methods for inhibiting and/or reducing self-reactive IgE and/or basophils, thereby treating or preventing lupus, lupus nephritis, and lupus-related disorders.

Abstract: A pump device (1) for administering a medical fluid to a patient comprises a holding device (10) for receiving a syringe barrel (20) of a syringe (2), the holding device (10) comprising a stationary section (101) and a holding member (11) movable with respect to the stationary section (101) between an opened position and a closed position, wherein the holding member (11) is configured to secure, in the closed position, the syringe barrel (20) of a syringe (2) received on the holding device (10) with respect to the stationary section (101). A shaft (130) is coupled to the holding member (11), the shaft (130) being constituted to rotate during a movement of the holding member (11).

Abstract: The present disclosure provides methods for inhibiting and/or reducing self-reactive IgE and/or basophils, thereby treating or preventing lupus, lupus nephritis, and lupus-related disorders.

Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.

Abstract: A non-pneumatic tire is described that includes a ground contacting annular tread portion, a shear band, wherein the shear band is formed of a first and second inextensible layer, and a low modulus material positioned between the first and second inextensible layer. The non-pneumatic tire further includes a connecting web positioned between a hub and the shear band, wherein the connecting web is formed of one or more spokes extending from an inner ring to an outer ring, wherein the one or more spokes are formed from a material reinforced with a three dimensional spacer structure.

Abstract: A textile jet subassembly includes a textile jet or jet nozzle mounted on a base support. An upper impact plate and a lower insert plate form the yarn channel passing through the jet or jet nozzle. A jet interface and a threading slot communicate with the yarn channel and the sidewalls above and below the threading slot are coplanar to form a smooth surface. Multiple alignment or registration recesses and cooperating pin fasteners are spaced from the yarn channel on the same side of the yarn channel to properly align the side walls above and below the threading slot.

Abstract: The present disclosure provides methods for inhibiting and/or reducing self-reactive IgE and/or basophils, thereby treating or preventing lupus, lupus nephritis, and lupus-related disorders.

Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.

Abstract: The present disclosure provides methods for inhibiting and/or reducing self-reactive IgE and/or basophils, thereby treating or preventing lupus, lupus nephritis, and lupus-related disorders.

Abstract: The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.

Abstract: A non-pneumatic tire is described that includes a ground contacting annular tread portion, a shear band, wherein the shear band is formed of a first and second inextensible layer, and a low modulus material positioned between the first and second inextensible layer. The non-pneumatic tire further includes a connecting web positioned between a hub and the shear band, wherein the connecting web is formed of one or more spokes extending from an inner ring to an outer ring, wherein the one or more spokes are formed from a material reinforced with a three dimensional spacer structure.

Abstract: The present disclosure provides methods for inhibiting and/or reducing self-reactive IgE and/or basophils, thereby treating or preventing lupus, lupus nephritis, and lupus-related disorders.

Abstract: The invention features compositions comprising agents that inhibit or reduce self-reactive IgE and/or basophils, and related methods of using the compositions for treating or preventing lupus, lupus nephritis, and lupus-related disorders.